Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Hanna Savolainen-Peltonen"'
Autor:
Merituuli Rekola, Kati Korhonen, Leila Unkila-Kallio, Henrik Alfthan, Vedran Stefanovic, Aila Tiitinen, Tomi S. Mikkola, Hanna Savolainen-Peltonen
Publikováno v:
Reproductive Biology and Endocrinology, Vol 22, Iss 1, Pp 1-8 (2024)
Abstract Background Erythropoietin (Epo) is a potent vascular growth factor that induces angiogenesis and antiapoptotic signalling. We investigated whether the development of numerous follicles and corpora lutea during in vitro fertilization (IVF) cy
Externí odkaz:
https://doaj.org/article/ec966a3dcfcb4a9c82310fec3fee0772
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Introduction Advances in multimodality cancer treatments have increased long‐term survival rates for early onset cancer patients, with 5‐year survival rates reaching 80% in Northern Europe. According to recent recommendations, clinicians
Externí odkaz:
https://doaj.org/article/c6e53b2ee6d34e5bac0b2538ae71e260
Autor:
Mika Gissler, Hanna Savolainen-Peltonen, Olavi Ylikorkala, Johanna Joensuu, Minttu Venetkoski, Tomi Sakari Mikkola
Publikováno v:
BMJ Open, Vol 12, Iss 12 (2022)
Objectives To investigate the impact of pre-eclampsia on the future cardiovascular risk in Finnish womenDesign A registry-based nationwide controlled cohort study.Setting Women hospitalised for pre-eclampsia in 1969–1993 and control women with a hi
Externí odkaz:
https://doaj.org/article/6780ae1db59a4787a8aabb43b322b680
Publikováno v:
Transgender Health. 7:505-513
Autor:
Aila Tiitinen, Juha S. Tapanainen, Kati V.M. Korhonen, Hanna Savolainen-Peltonen, Tomi S. Mikkola, Henrik Alfthan, Esa Hämäläinen, Leila Unkila-Kallio
Publikováno v:
Archives of Gynecology and Obstetrics
Purpose Pentraxin 3 (PTX3) is a locally secreted, quicker responsive pro-inflammatory protein than C-reactive protein (CRP). We evaluated the value of PTX3 in the prediction of ovarian hyperstimulation syndrome (OHSS), a severe complication of in vit
Autor:
Minttu Venetkoski, Johanna Joensuu, Mika Gissler, Olavi Ylikorkala, Tomi Sakari Mikkola, Hanna Savolainen-Peltonen
Publikováno v:
BMJ Open. 12:e064736
ObjectivesTo investigate the impact of pre-eclampsia on the future cardiovascular risk in Finnish womenDesignA registry-based nationwide controlled cohort study.SettingWomen hospitalised for pre-eclampsia in 1969–1993 and control women with a histo
Autor:
Alexandra Robciuc, Hanna Savolainen-Peltonen, Mikko Haanpää, Jukka A. O. Moilanen, Tomi S. Mikkola
Publikováno v:
International Journal of Molecular Sciences. 23:14864
The marked sexual dimorphism prevalent in inflammatory/autoimmune diseases is mostly due to sex hormone actions. One common eye disease that disproportionately affects women is dry eye. Thus, our aim was to optimise our highly sensitive liquid chroma
Autor:
Päivi Rahkola-Soisalo, Hanna Savolainen-Peltonen, Olavi Ylikorkala, Fabian Hoti, Mika Gissler, Tomi S. Mikkola, Pia Vattulainen
Publikováno v:
Menopause. 26:140-144
OBJECTIVE Receptors for estrogen and progesterone are present in the pelvic floor, and therefore, postmenopausal hormone therapy may affect its function. We compared the former use of estradiol-progestogen postmenopausal hormone therapy in nonhystere
Autor:
Hanna Savolainen-Peltonen, Ursula Turpeinen, Esa Hämäläinen, Tomi S. Mikkola, Matti J. Tikkanen, Natalia Hetemäki, Veera Vihma, Feng Wang, Mikko Haanpää
Objective: Although the ovaries produce the majority of estrogens in women before menopause, estrogen is also synthesized in peripheral tissues such as adipose tissue (AT). The typical female AT distribution, concentrated in subcutaneous and femoro-g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6288cbee6d2cc64cf7415372239648d3
http://hdl.handle.net/10138/330826
http://hdl.handle.net/10138/330826
Autor:
Päivi Rahkola-Soisalo, Mika Gissler, Hanna Savolainen-Peltonen, Fabian Hoti, Tomi S. Mikkola, Olavi Ylikorkala, Pia Vattulainen
Publikováno v:
International Urogynecology Journal. 30:251-256
Introduction and hypothesisThe impact of estradiol-based hormone therapy (HT) on the incidence of stress urinary incontinence (SUI) is unknown. Therefore, we compared the use of such HT regimens and tibolone in women with and without SUI.MethodsThe w